In addition, a single‐center study29 showed that the inclusion of NT‐proBNP in the CHA2DS2‐VASc score increased the predictive ability of the risk of IS or systemic thromboembolism by 17% in anticoagulated patients with AF. The gene discussed is NPPB; the disease is atrial fibrillation.